SFX by Ex Libris Inc.

Title:	Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination
Source:	Nature Medicine [1078-8956] Pütz, Mike yr:2006

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Reeves, D. "Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases." Nature medicine 11.8 (2005): 731-9.
description	2.	Klote MM, M. "Absence of oropharyngeal vaccinia virus after vaccinia (smallpox) vaccination." Annals of allergy, asthma, & immunology 94.6 (2005): 682-5.
description	3.	Belongia, E. "Smallpox vaccine: the good, the bad, and the ugly." Clinical medicine & research 1.2 (2003): 87-92.
description	4.	Pearson, H. "Controlling immune response may cut bird flu death rate." Nature medicine 12.10 (2006): 1105-1105.
description	5.	Moghaddam, A. "A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines." Nature medicine 12.8 (2006): 905-7.
description	6.	Lee, Jong S. "Ginseng Protects Against Respiratory Syncytial Virus by Modulating Multiple Immune Cells and Inhibiting Viral Replication." Nutrients 7.2 (2015): 1021-1036.
description	7.	Mcfadden, G. "Gleevec casts a pox on poxviruses." Nature Medicine 11.7 (2005): 711-2.
description	8.	Sandusky, M. "Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation." European journal of immunology 36.12 (2006): 3268-3276.
description	9.	McKenna, M. "Anatomy of a pandemic: Emergency departments woefully unprepared for bird flu outbreak." Annals of emergency medicine 48.3 (2006): 312-314.
description	10.	Gunji, A. "Auditory feedback in children with autism: A reduced Lombard effect." Neuroscience research 55 (2006).
description	11.	Schneider, Michael D. P. ""The king of terrors" revisited: the smallpox vaccination campaign and its lessons for future biopreparedness." The Journal of law, medicine & ethics 31.4 (2003): 580-9.
description	12.	Edghill-Smith, Y. "Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus." Nature medicine 11.7 (2005): 740-7.
description	13.	Neff, J. "The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program." Vaccine 23.17-18 (2005): 2078-81.
description	14.	Letai, Anthony G G. "Smallpox and smallpox vaccination." New England Journal of Medicine, The 348.19 (2003): 1920-5.
description	15.	Ye, Q. "The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA." Nature 444.7122 (2006): 1078-1082.
description	16.	Friel, H. "A nutritional supplement formula for influenza A (H5N1) infection in humans." Medical Hypotheses 67.3 (2006): 578-587.
description	17.	Nafziger, Sarah D D. "Smallpox." Critical care clinics 21.4 (2005): 739-46.
description	18.	Alcamí, A. "Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus." Trends in microbiology 4.8: 321-326.
description	19.	Jefferson, T. "Influenza vaccination: policy versus evidence." BMJ 333.7576 (2006): 912-5.
description	20.	Wright, Peter F F. "The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans." The journal of infectious diseases 193.4 (2006): 573-81.